BTC $62,991.82 -2.93%
ETH $1,774.66 -2.64%
BNB $582.47 -2.27%
XRP $0.9667 -1.52%
SOL $73.58 -2.06%
TRX $0.3094 +0.53%
DOGE $0.0587 -2.19%
ADA $0.1513 -2.49%
BCH $208.67 -1.61%
LINK $9.08 -2.51%
HYPE $66.93 -4.17%
AAVE $109.33 -2.87%
SUI $0.7203 -2.34%
XLM $0.1374 -2.82%
ZEC $914.51 -5.49%
AAPL $354.15 +0.88%
AMZN $270.08 +3.83%
GOOGL $285.64 +0.78%
MSFT $511.85 +0.31%
META $619.54 -0.51%
NVDA $151.97 -5.61%
TSLA $385.42 +0.27%
SNDK $783.92 -6.42%
INTC $55.51 -1.47%
SPCX $144.71 +1.00%
MU $713.35 -3.97%
AMD $534.29 +2.25%
BTC $62,991.82 -2.93%
ETH $1,774.66 -2.64%
BNB $582.47 -2.27%
XRP $0.9667 -1.52%
SOL $73.58 -2.06%
TRX $0.3094 +0.53%
DOGE $0.0587 -2.19%
ADA $0.1513 -2.49%
BCH $208.67 -1.61%
LINK $9.08 -2.51%
HYPE $66.93 -4.17%
AAVE $109.33 -2.87%
SUI $0.7203 -2.34%
XLM $0.1374 -2.82%
ZEC $914.51 -5.49%
AAPL $354.15 +0.88%
AMZN $270.08 +3.83%
GOOGL $285.64 +0.78%
MSFT $511.85 +0.31%
META $619.54 -0.51%
NVDA $151.97 -5.61%
TSLA $385.42 +0.27%
SNDK $783.92 -6.42%
INTC $55.51 -1.47%
SPCX $144.71 +1.00%
MU $713.35 -3.97%
AMD $534.29 +2.25%

The board of directors of Nasdaq-listed company Anixa Biosciences has approved the purchase of Bitcoin as a reserve asset

2024-11-22 21:39:42

ChainCatcher news, according to PR Newswire, the NASDAQ-listed company Anixa Biosciences, Inc. (NASDAQ: ANIX) announced that its board has approved the purchase of Bitcoin as a treasury reserve asset, aimed at diversifying the company's assets while allowing Anixa to benefit from the potential long-term value of digital assets.

It is reported that Anixa is a clinical-stage biotechnology company focused on cancer treatment and prevention.

链捕手ChainCatcher nhắc nhở: hãy nhìn nhận blockchain một cách tỉnh táo, nâng cao ý thức rủi ro, cảnh giác với việc phát hành và đầu cơ các token ảo. Mọi nội dung trên trang chỉ là thông tin thị trường hoặc quan điểm của các bên liên quan, không cấu thành bất kỳ hình thức tư vấn đầu tư nào. Nếu phát hiện nội dung nhạy cảm, hãy nhấp , chúng tôi sẽ xử lý kịp thời.

app_icon
ChainCatcher Building the Web3 world with innovations.